eFFECTOR Therapeutics Statistics
Share Statistics
eFFECTOR Therapeutics has 4.70M shares outstanding. The number of shares has increased by 27.58% in one year.
| Shares Outstanding | 4.70M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.23M |
| Failed to Deliver (FTD) Shares | 12 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 91.62K, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 91.62K |
| Short % of Shares Out | 1.95% |
| Short % of Float | 2.17% |
| Short Ratio (days to cover) | 0.97 |
Valuation Ratios
The PE ratio is -0.71 and the forward PE ratio is null.
| PE Ratio | -0.71 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -4.41 |
| P/FCF Ratio | -0.86 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for eFFECTOR Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.77, with a Debt / Equity ratio of -3.55.
| Current Ratio | 0.77 |
| Quick Ratio | 0.77 |
| Debt / Equity | -3.55 |
| Total Debt / Capitalization | 139.29 |
| Cash Flow / Debt | -1.44 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 6.18% and return on capital (ROIC) is -229.45%.
| Return on Equity (ROE) | 6.18% |
| Return on Assets (ROA) | -1.74% |
| Return on Capital (ROIC) | -229.45% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.56M |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.8, so eFFECTOR Therapeutics 's price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0 |
| 200-Day Moving Average | 0.91 |
| Relative Strength Index (RSI) | 33.83 |
| Average Volume (20 Days) | 18.22K |
Income Statement
| Revenue | n/a |
| Gross Profit | -22.92M |
| Operating Income | -33.84M |
| Net Income | -35.81M |
| EBITDA | -33.73M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -16.37 |
Balance Sheet
The company has 14.88M in cash and 20.55M in debt, giving a net cash position of -5.67M.
| Cash & Cash Equivalents | 14.88M |
| Total Debt | 20.55M |
| Net Cash | -5.67M |
| Retained Earnings | -179.38M |
| Total Assets | 27.13M |
| Working Capital | 681.00K |
Cash Flow
In the last 12 months, operating cash flow was -29.55M and capital expenditures -97.00K, giving a free cash flow of -29.65M.
| Operating Cash Flow | -29.55M |
| Capital Expenditures | -97.00K |
| Free Cash Flow | -29.65M |
| FCF Per Share | -13.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EFTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | -3150584.48% |
Analyst Forecast
Currently there are no analyst rating for EFTR.
| Price Target | $24 |
| Price Target Difference | n/a |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jan 12, 2024. It was a backward split with a ratio of 1:25.
| Last Split Date | Jan 12, 2024 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -13.63 |
| Piotroski F-Score | 2 |